Therapeutic Asset Ratings
435 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ERIBULIN MONOMETHANESULFONATE
Scrotum Cancer
OHSU Knight Cancer Institute
P1
CC
(43)
ERIBULIN MONOMETHANESULFONATE
Spermatic Cord Cancer
OHSU Knight Cancer Institute
P1
CC
(43)
Iadademstat
Myelodysplastic Syndrome/Acute Myeloid Leukemia
OHSU Knight Cancer Institute
P1
CC
(43)
Omo-103
Malignant Pancreatic Neoplasm
OHSU Knight Cancer Institute
P1
CC
(43)
Axatilimab
Metastatic Malignant Neoplasm
OHSU Knight Cancer Institute
P1/2
CC
(43)
PARAFFINUM FLAVUM
Radiation-Induced Dermatitis
OHSU Knight Cancer Institute
P1/2
CC
(43)
Calaspargase Pegol
Pancreatic Adenocarcinoma
OHSU Knight Cancer Institute
P1
CC
(41)
Calaspargase Pegol
Malignant Pancreatic Neoplasm
OHSU Knight Cancer Institute
P1
CC
(41)
Neratinib
Refractory Malignant Neoplasm
OHSU Knight Cancer Institute
P1
CC
(41)
Venetoclax
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
OHSU Knight Cancer Institute
P1
CC
(41)
Everolimus
Myelodysplastic Syndrome
OHSU Knight Cancer Institute
P1
C
(39)
Neratinib
Metastatic Malignant Neoplasm
OHSU Knight Cancer Institute
P1
C
(39)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Borderline Resectable Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Breast Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Ovarian Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Ovarian Cancer
OHSU Knight Cancer Institute
Early P1
C
(39)
Alpelisib
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Alpelisib
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Alpelisib
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Alpelisib
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Arimidex
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Arimidex
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Showing 326 to 350 of 435 assets
Previous
Page 14 of 18
Next
